Transient deafness with iopamidol following angiography. | Canada Hyperbarics Skip to main content
Clinical Study Acta oto-laryngologica. Supplementum 1994

Transient deafness with iopamidol following angiography.

Matsuoka A, Shitara T, Okamoto M, Sano H — Acta oto-laryngologica. Supplementum, 1994

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported a case of transient, severe sensorineural hearing loss in a 26-year-old woman following angiography with iopamidol.

What They Found

The patient experienced immediate, severe sensorineural hearing loss in both ears (no ABR response at 105 dB) after a second injection of iopamidol during vertebral angiography. Her hearing fortunately recovered to a normal conversation level within 24 hours, with the transient loss attributed to cochlear anoxia lasting 10-20 minutes.

What This Means for Canadian Patients

Canadian clinicians should be aware of the extremely rare potential for transient severe hearing loss as a complication of iopamidol angiography. Patients undergoing such procedures should be monitored for sudden changes in hearing, though this event is highly uncommon.

Canadian Relevance

This study has no direct Canadian connection as it is a case report from Japan.

Study Limitations

As a single case report, the findings cannot be generalized to a broader patient population.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 8073892
Year Published 1994
Journal Acta oto-laryngologica. Supplementum
MeSH Terms Adult; Angiography; Arnold-Chiari Malformation; Audiometry, Pure-Tone; Cochlea; Deafness; Evoked Potentials, Auditory, Brain Stem; Female; Hearing Loss, Sensorineural; Humans; Hyperbaric Oxygenation; Iopamidol; Ischemia; Methylprednisolone

Cite This Study

Share

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.